Latest News about ASND
Recent news which mentions ASND
Pfizer's Growth Hormone Candidate FDA Review Pushed By 3 Months
September 27, 2021
From Benzinga
The Daily Biotech Pulse: Restricted Authorization For Pfizer's COVID-19 Booster Dose, AbCellera Strikes Antibody Licensing Deal, Solid Biosciences Issues DMD Data
September 23, 2021
From Benzinga
The Daily Biotech Pulse: MacroGenics' Clinical Trial Disappointment, Sanofi to Buy Kadmon, Alector Loses 2 Key Executives, ADMA's FDA Nod
September 08, 2021
From Benzinga
The Daily Biotech Pulse: Merck Releases Twin Dose Of Positive Tidings, Astellas Voluntarily Pauses Gene Therapy Study, Ascendis Offering
September 01, 2021
From Benzinga
From Benzinga
The Week Ahead In Biotech (Aug. 29- Sept. 4): Merck's Keytruda Regulatory Decision, Stray Earnings On Tap In a Light Week
August 29, 2021
From Benzinga
Ascendis Pharma A/S (ASND) Q2 2021 Earnings Call Transcript
August 28, 2021
Tickers
ASND
From Motley Fool
63 Biggest Movers From Yesterday
August 27, 2021
From Benzinga
Mid-Afternoon Market Update: Pure Storage Rises Following Strong Q2 Results; SelectQuote Shares Plunge
August 26, 2021
From Benzinga
Here's Why Ascendis Pharma Shares Are Surging Higher Today
August 26, 2021
From Motley Fool
Mid-Day Market Update: Dow Tumbles Over 100 Points; Ascendis Pharma Shares Spike Higher
August 26, 2021
From Benzinga
45 Stocks Moving In Thursday's Mid-Day Session
August 26, 2021
From Benzinga
See Why Ascendis Pharma Stock Is Shining On Thursday
August 26, 2021
From Benzinga
From Benzinga
From Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
August 26, 2021
From Benzinga
22 Stocks Moving in Thursday's Pre-Market Session
August 26, 2021
From Benzinga
These 2 Stocks Soared Double Digits After Hours
August 25, 2021
From Motley Fool
12 Health Care Stocks Moving In Wednesday's After-Market Session
August 25, 2021
From Benzinga
From Benzinga
Earnings Scheduled For August 25, 2021
August 25, 2021
From Benzinga
The Week Ahead In Biotech: Cara FDA Decision, Ascendis Earnings, Aileron Data Presentation And More
August 22, 2021
From Benzinga
Get Ready for a Potential Double in This Biopharmaceutical Stock in the Next 6 to 12 Months
August 20, 2021
From Motley Fool
From Benzinga
From Benzinga
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.